Safety, Tolerability, and Clinical Response After Fecal Transplantation in Children and Young Adults With Ulcerative Colitis
The DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND OBJECTIVE: Colonic dysbiosis contributes to the development of colonic inflammation in ulcerative colitis (UC). Fecal microbial transplantation (FMT) is being proposed as a novel treatment for UC because it can eliminate dysbiosis; however, no prospective data exist. We initiated a pilot study to evaluate feasibility and safety of FMT in children with UC. METHODS: Ten children, 7 to 21 years of age, with mild-to-moderate UC (pediatric UC activity index [PUCAI] between 15 and 65) received freshly prepared fecal enemas daily for 5 days. Data on tolerability, adverse events, and disease activity were collected during FMT and weekly for 4 weeks after FMT. Clinical response was defined as decrease in PUCAI by >15, and decrease in PUCAI to <10 was considered clinical remission. RESULTS: No serious adverse events were noted. Mild (cramping, fullness, flatulence, bloating, diarrhea, and blood in stool) to moderate (fever) adverse events were self-limiting. One subject could not retain fecal enemas. Average tolerated enema volume by remaining 9 subjects was 165 mL/day. After FMT, 7 of the 9 (78%) subjects showed clinical response within 1 week, 6 of the 9 (67%) subjects maintained clinical response at 1 month, and 3 of the 9 (33%) subjects achieved clinical remission at 1 week after FMT. Median PUCAI significantly improved after FMT (P = 0.03) compared with the baseline. CONCLUSIONS: Fecal enemas were feasible and tolerated by children with UC. Adverse events were acceptable, self-limiting, and manageable by subjects. FMT indicated efficacy in the treatment of UC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These reports were followed by a number of small studies of FMT in children and adults with UC, CD, and pouchitis with mixed results.64–72”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [68]
Citations
Cites
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708 · cited 6×
“A recent study (7) evaluating the role of FMT in treating recurrent C difficile infection reported adverse events, which, similar to our study, were predominantly GI symptoms.”
BackgroundMethodResultInfluentialDysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
Morgan, X. C., Tickle, T. L., Sokol, H., Gevers, D., Devaney, K. L., Ward, D. V., Reyes, J. A., Shah, S. A., LeLeiko, N., Snapper, S. B., et al. (2012) · Genome Biology · doi:10.1186/gb-2012-13-9-r79 · Cited by 2,713 · cited 1×
“The colonic microbiome in patients with UC has decreased richness and diversity (2,3) and is dysfunctional (4) (dysbiosis).”
BackgroundTurner, D., Otley, A. R., Mack, D., Hyams, J., de Bruijne, J., Uusoue, K., Walters, T. D., Zachos, M., Mamula, P., Beaton, D. E., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.029 · Cited by 1,072 · cited 2×
“Therefore, clinical response was defined as a decrease in PUCAI by >15 points after FMT (17).”
BackgroundMethodTreating Clostridium difficile infection with fecal microbiota transplantation
Bakken, J. S., Borody, T., Brandt, L. J., Brill, J. V., Demarco, D. C., Franzos, M. A., Kelly, C., Khoruts, A., Louie, T., Martinelli, L. P., et al. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.08.014 · Cited by 1,003 · cited 2×
“Donor exclusion criteria were guided by our IND, the American Association of Blood Bank Donor History Questionnaire version 1.1, and the recommendations from the American Gastroenterological Association (16).”
BackgroundInfluentialHamilton, M. J., Weingarden, A. R., Sadowsky, M. J., & Khoruts, A. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.482 · Cited by 738 · cited 1×
“Multiple studies have used various bowel sterilizing preparations (antibiotics and bowel cleanout) before FMT (19,20) to help donor microbiota establish in the new host.”
BackgroundKhoruts, A., Dicksved, J., Jansson, J. K., & Sadowsky, M. J. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181c87e02 · Cited by 649 · cited 2×
“Recent evidence suggests that FMT, the infusion of fecal preparation from a healthy donor into the GI tract of a patient, is capable of altering the gut microbiome of the new host (6,7).”
BackgroundMethodGophna, U., Sommerfeld, K., Gophna, S., Doolittle, W. F., & Veldhuyzen van Zanten, S. J. O. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01004-06 · Cited by 550
Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases
Peterson, D. A., Frank, D. N., Pace, N. R., & Gordon, J. I. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.05.001 · Cited by 503 · cited 1×
“The colonic microbiome in patients with UC has decreased richness and diversity (2,3) and is dysfunctional (4) (dysbiosis).”
BackgroundTursi, A., Brandimarte, G., Papa, A., Giglio, A., Elisei, W., Giorgetti, G. M., Forti, G., Morini, S., Hassan, C., Pistoia, M. A., et al. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.218 · Cited by 489 · cited 1×
“Probiotics, for example, VSL#3, have shown some usefulness in the treatment of UC (5); however, not all probiotic formulations contain the same species, their efficacy may be strain specific, and understanding of their mechanism of action in the complex gastrointestinal (GI) microbiome is lacking.”
BackgroundTreatment of Ulcerative Colitis Using Fecal Bacteriotherapy
Borody, T. J., Warren, E. F., Leis, S., Surace, R., & Ashman, O. (2003) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200307000-00012 · Cited by 388 · cited 3×
“As reported previously (10), because of the chronic process of colonic inflammation, multiple FMT sessions may be needed to see a clinical response in UC.”
BackgroundMethod
Cited by
Items 201–300 of 343
Fifteen Years of Probiotic Therapy in the Dental Context: What Has Been Achieved?
Twetman, S., Jørgensen, M. R., & Keller, M. K. (2017) · Journal of the California Dental Association · doi:10.1080/19424396.2017.12222503 · Cited by 14
Prospects and challenges for intestinal microbiome therapy in pediatric gastrointestinal disorders
Kellermayer, R. (2013) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v4.i4.91 · Cited by 14
Faecal Microbiota Transplantation as Emerging Treatment in European Countries
Maida, M. F., Mcilroy, J. R., Ianiro, G., & Cammarota, G. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-72799-8_11 · Cited by 14
Li, M., Li, Z., Shu, W., Liu, Y., Wang, Y., & Tang, L. (2016) · Future Microbiology · doi:10.2217/fmb-2015-0002 · Cited by 13
Fecal Microbiota Transplantation for Ulcerative Colitis. Are We Ready for Primetime?
Cheng, Y., & Fischer, M. (2020) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2020.08.006 · Cited by 12
Prospects of Using Microbiota Correction Methods in the Treatment of Inflammatory Bowel Disease
Akinshina, A. I., Smirnova, D. V., Zagaynova, A. V., Makarov, V. V., & Yudin, S. M. (2019) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2019-29-2-12-22 · Cited by 12
“Положительный клинический ответ в течение 1 недели достигнут у 7 из 10 пациентов, а у 6 из 9 пациентов поддерживался в течение 1 месяца [76].”
Le transfert de flore digestive : une revue de la littérature
Barbut, F., Collignon, A., Butel, M. J., & Bourlioux, P. (2014) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2014.05.004 · Cited by 12
Synergism of Diet, Genetics, and Microbiome on Health
Das, P., Banka, R., Ghosh, J., Singh, K., Choudhury, S. R., & Koner, S. (2024) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/979-8-3693-5528-2.ch006 · Cited by 11
Biegańska, E. A., Kosinski, P. D., & Wolski, M. (2025) · Biomedicines · doi:10.3390/biomedicines13061393 · Cited by 11
Khajah, M. A. (2017) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2017.1347812 · Cited by 11
“cedure was seen in UC patients with mild to moderate disease activity [83,98,103].”
BackgroundShould We Be Treating the Bugs instead of Cytokines and T Cells?
Wine, E. (2014) · Digestive Diseases · doi:10.1159/000358146 · Cited by 11
Afecciones de Salud Mental y el Proceso de Retorno al Trabajo: Una Revisión Sistemática
Larrea, P. G., Ansoleaga, E., Suñer, A. T., Domínguez, C., Vergara, S. C., Chenevard, C. L., & Guzmán, C. M. (2013) · Ciencia & trabajo · doi:10.4067/s0718-24492013000300002 · Cited by 11
Ramos, R. J., Zhu, C., Joseph, D. F., Thaker, S., LaComb, J. F., Markarian, K., Lee, H., Petrov, J. C., Monzur, F., Buscaglia, J. M., et al. (2022) · Medical Research Archives · doi:10.18103/mra.v10i10.3318 · Cited by 10
Ottria, R., Xynomilakis, O., Casati, S., & Ciuffreda, P. (2024) · Microorganisms · doi:10.3390/microorganisms12081582 · Cited by 10
Ding, X. L., Yang, X., & Wang, H. (2020) · Medicine in Microecology · doi:10.1016/j.medmic.2020.100028 · Cited by 10
Tungland, B. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814649-1.00009-0 · Cited by 10
The Antimicrobial Therapy of the Future: Combating Resistances
Suay‐García, B. (2014) · Journal of Infectious Diseases and Therapy · doi:10.4172/2332-0877.1000146 · Cited by 11
“This therapy has shown to be so safe and effective that its application in children is already being studied [26].”
BackgroundEl-Azab, N. E.-E., Salem, M. Y., & Morsy, S. A. E.-S. (2016) · The Egyptian Journal of Histology · doi:10.1097/01.ehx.0000481746.43677.e1 · Cited by 10
Cui, B., Li, P., Xu, L., Peng, Z., Zhao, Y., Wang, H., He, Z., Zhang, T., Ji, G., Wu, K., et al. (2015) · Inflammation and Cell Signaling · doi:10.14800/ics.757 · Cited by 9
Dietert, R. R. (2013) · Journal of Ancient Diseases & Preventive Remedies · doi:10.4172/2329-8731.1000103 · Cited by 9
“One of the suggested solutions for mucosal immune-microbiome dysbiosis and the associated elevated risk of both acute infections as well as chronic diseases has been fecal microbial transplantation [50,51].”
BackgroundFaecal transplantation for IBD management—pitfalls and promises
Quraishi, M. N., Critchlow, T., Bhala, N. B., Sharma, N., & Iqbal, T. H. (2017) · British Medical Bulletin · doi:10.1093/bmb/ldx040 · Cited by 9
radwan, H., Mansy, A. E., Mohamed, O. S. A., & Helal, O. (2019) · The Egyptian Journal of Histology · doi:10.21608/ejh.2019.10575.1100 · Cited by 9
“So, the patient complain of bloody diarrhea, abdominal spasms and weight loss[2].”
BackgroundFecal Microbiota Transplantation: Just a Fancy Trend?
Vandenplas, Y., Piérard, D., & Greef, E. D. (2015) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000816 · Cited by 9
“Kelly et al (17) Clostridium difficile 5(/80) ? ? Kronman et al (12) C difficile 10 Positive (90%) Safe Kunde et al (18) UC 10 Moderate Safe Pierog et al (19) C difficile 6 Positive (100%) Safe Russell et al (11) C difficile 10 Positive (90%) Safe Suskind et al (14) UC 4 Negative Safe Vandenplas and Veereman (13) IC 1…”
BackgroundSamuel, B. P., Crumb, T. L., & Duba, M. M. (2014) · Journal of Pediatric Nursing · doi:10.1016/j.pedn.2014.01.013 · Cited by 9
Self-citationHaller, D., & Hörmannsperger, G. (2015) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-014-2095-0 · Cited by 9
Liu, Q., Zhang, X., Li, Z., Chen, Y., Yin, Y., Lu, Z., Ou-Yang, M., & Chen, L. (2022) · Nutrition · doi:10.1016/j.nut.2022.111672 · Cited by 8
Stallmach, A., Grunert, P., Pieper, D. H., & Steube, A. (2019) · Zeitschrift für Gastroenterologie · doi:10.1055/a-0874-6603 · Cited by 8
“…Diarrhö (5/5), Flatulenz (1/5), Erythem (1/5), Übelkeit 1/5) Pankreatitis (1/5) Kump et al. 2013 [63] Koloskopie Diarrhö und Fieber (1/6) keine Kunde et al. 2013 [64] Einläufe Blähungen (9/9), abdominelle Krämpfe (6/9), Diarrhö (6/9), Blut im Stuhl (3/9), Fatigue 2/9) keine Suskind et al.…”
Effect of intestinal microbiome in norm and pathology on human health
Lifshitz, L., Zakharova, I. N., & Dmitrieva, Y. А. (2017) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2017-1-155-159 · Cited by 8
Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Where We Stand and What Is Next
Ishikawa, D., Zhang, X., Nomura, K., & Nagahara, A. (2025) · Inflammatory Intestinal Diseases · doi:10.1159/000549227 · Cited by 7
Ko, Y., Alaeddin, S., Fernando, D., Zhou, J., & Ho, V. (2024) · Medicina · doi:10.3390/medicina60111899 · Cited by 7
Guan, Z., Niu, P., Tan, Q., Wang, Y., Deng, S., Wang, D., Dong, K., Xing, J., & You, C. (2025) · Materials Advances · doi:10.1039/d4ma00896k · Cited by 7
Bell, J., Raidal, S. L., Peters, A., & Hughes, K. (2024) · The Veterinary Journal · doi:10.1016/j.tvjl.2024.106220 · Cited by 7
Fecal Microbiota Transplantation
Borody, T. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-54843-4.00018-0 · Cited by 7
Genetics and Therapeutics in Pediatric Ulcerative Colitis: the Past, Present and Future
Sifuentes-Dominguez, L., & Patel, A. (2016) · F1000Research · doi:10.12688/f1000research.7440.1 · Cited by 7
Le, J., Hakimjavadi, H., Parsana, R., Chamala, S., & Michail, S. K. (2025) · Gastro Hep Advances · doi:10.1016/j.gastha.2025.100741 · Cited by 6
“Our study revealed significant changes in microbial diversity associated with FMT.”
InfluentialSinghal, R., Ghadvaje, G., Karra, N., Gadde, S. T., Chandra, P., Voruganti, B., Doddareddy, N. P., Iftikhar, S., & Patel, T. D. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003841 · Cited by 6
“Studies on mild to moderate UC cases, like those by Sarbagili et al , Rossen et al , and Kunde et al , report common, mild AEs (e.g., abdominal pain, diarrhea, and fever) from colonoscopy, nasoduodenal infusions, and enemas [ 11 , 14 , 36 ] .”
Newman, K. M., & Vaughn, B. P. (2020) · Minerva Gastroenterologica e Dietologica · doi:10.23736/s1121-421x.19.02610-2 · Cited by 6
Effect of Pentoxifylline on Experimental-dextran Sulphate Sodium-induced Colitis in Rats
Al-Gholam, M. A.-S. (2014) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2014/5108 · Cited by 6
“It has many symptoms as; abdominal pain, cramping, bloody diarrhea, pus stool, fever, rectal pain, weight loss, nausea, vomiting, arthritis, mouth sores and children growth retard [2].”
BackgroundModernity and tradition in medicine
Ansaripour, M., Naseri, M., Esfehani, M. M., Nabipour, I., & Rakhshani, F. (2017) · Tārīkh-i pizishkī i.e., Medical History · doi:10.22037/mhj.v9i30.17415 · Cited by 6
New treatments for ulcerative colitis: do we have pediatric data?
Russell, R. K., Hansen, R., & Turner, D. (2016) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2016.1177459 · Cited by 6
Fecal transplantation: re-discovering the value of stool
Davidovics, Z. H., & Hyams, J. S. (2013) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e328363ed66 · Cited by 5
Consenso colombiano de la enfermedad inflamatoria intestinal pediátrica
Chamorro, J. F. V., Franco, C. P. S., Sandoval, M. V., Quintero, D. V. M., López, J. P. R., Quintero, F., Ortiz‐Piedrahita, C., Calderón-Guerrero, O. G., Hernández, H. H. L., Gómez, C. L. L., et al. (2023) · Revista Colombiana de Gastroenterología · doi:10.22516/25007440.943 · Cited by 5
The Equine Intestinal Microbiota
Weese, J. S. (2017) · Wiley eBooks · doi:10.1002/9781119063254.ch7 · Cited by 5
Zhang, X., Ishikawa, D., & Nagahara, A. (2025) · International Immunology · doi:10.1093/intimm/dxaf038 · Cited by 4
Alternative & complementary treatment for pediatric inflammatory bowel disease
Rimon, R. M., & Shaoul, R. R. (2019) · Translational Pediatrics · doi:10.21037/tp.2019.09.02 · Cited by 4
“In another small pediatric trial, 10 patients with mildmoderate UC received FMT via daily enemas for 5 days (22).”
Marsiglia, R., Pane, S., CHIERICO, F. D., Russo, A., Vernocchi, P., Romani, L., Cardile, S., Diamanti, A., Galli, L., Tamborino, A. M., et al. (2024) · Microorganisms · doi:10.3390/microorganisms12102059 · Cited by 4
“Amongst the different pathological conditions, FMT has been tested in children with IBD and has been shown to be safe and effective in managing symptoms [29,30].”
BackgroundA bug's view of allergic airways disease
Hsu, P. S., & Campbell, D. E. (2016) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2016.02.002 · Cited by 4
Chapter 10 The intestinal microbiota and allergic and auto-immune disorders in children
de Meij, T. G. J. (2017) · Wageningen Academic Publishers eBooks · doi:10.3920/978-90-8686-839-1_10 · Cited by 4
Gudka, R., & Nyinoh, I. W. (2023) · Frontiers in Microbiomes · doi:10.3389/frmbi.2023.1222089 · Cited by 4
Diets for Autism Spectrum Disorder: Learning from IBD and IBS Treatments
Ferro, P., & Prasad, R. (2016) · Alternative and Complementary Therapies · doi:10.1089/act.2016.29046.pfe · Cited by 4
Schulte, L.-A., Schäfer, A., Steding, K., Rauschek, L., & Klaus, J. (2019) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1010-6920 · Cited by 4
Hmar, E. B. L., Paul, S., Boruah, N., Sarkar, P., Borah, S., & Sharma, H. K. (2021) · Current Pathobiology Reports · doi:10.1007/s40139-020-00218-6 · Cited by 4
Fecal Microbiota Transplantation: Clinical and experimental studies
van Nood, E. (2015) · Data Archiving and Networked Services (DANS) · Cited by 4
Liu, J., Sun, X., Yuan, P., Qin, Y., Wu, W., Fan, Y., Zhang, Y., Zou, L., Ren, C., & Li, S. (2026) · European Journal of Pediatrics · doi:10.1007/s00431-026-06880-z · Cited by 3
Das, K., Upadhyay, S., & Oli, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99988-5.00021-8 · Cited by 3
Qadir, S. A., ALKaisy, Q. H., Hasan, A. F., Awlqadr, F. H., Altemimi, A. B., Faraj, A. M., Giuffrè, A. M., Saeed, M. N., & Abdalla, S. R. (2024) · Kurdistan Journal of Applied Research · doi:10.24017/science.2024.2.6 · Cited by 3
“After conducting several trials involving a small number of pediatric patients that produced inconsistent findings [59, 60].”
BackgroundParallels Between Mammals and Flies in Inflammatory Bowel Disease
Christofi, T., & Apidianakis, Y. (2015) · Healthy ageing and longevity · doi:10.1007/978-3-319-18326-8_7 · Cited by 3
“Fecal microbiota transplantation is a newer approach with promising results as it is associated with beneficial changes in fecal bacterial diversity and it was successful in treating IBD in a number of cases (van Nood et al. 2013; Kao et al. 2014; Kunde et al. 2013).”
BackgroundFecal Microbiota Transplants as a Treatment Option for Parkinson’s Disease
Flameling, I. A., & Rijkers, G. T. (2018) · IntechOpen eBooks · doi:10.5772/intechopen.78666 · Cited by 3
FMT in Clostridium difficile and Other Potential Uses
Fine, S., & Kelly, C. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804024-9.00034-3 · Cited by 3
Trasplante de microbiota fecal en niño con enfermedad inflamatoria intestinal de inicio muy precoz
Salinas, C. S., Recio, M. I. V., Blasco‐Alonso, J., Nieto, M. J. S., & Navas‐López, V. M. (2017) · Anales de Pediatría · doi:10.1016/j.anpedi.2017.10.011 · Cited by 3
The guide through brain-gut-enteric microbiota axis - regulation pathways and related disorders
Kolasińska, K., Kwiatkowski, S., Knap, B., Czerwiński, G., Poniewierka, E., & Waszczuk, E. (2018) · World Scientific News · Cited by 2
Rao, A., & Gokhale, R. R. (2021) · Springer eBooks · doi:10.1007/978-3-030-80068-0_30 · Cited by 2
Fecal transplantation: clinical realities and prospects in the treatment of metabolic syndrome
Sas, E. I., Grinevich, V. B., & Barnakova, V. A. (2020) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-183-11-102-112 · Cited by 2
Ulcerative Colitis in Children and Adolescents
Bitton, S., & Markowitz, J. F. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-67293-1.00043-8 · Cited by 2
Faecal microbiota transplantation associated adverse events
Patryn, R. K., Kaźmierczak-Wojtaś, N., Bułaś, L., Boretska, O., Szkultecka-Dębek, M., Drozd, M., & Blicharski, T. (2024) · Current Issues in Pharmacy and Medical Sciences · doi:10.2478/cipms-2024-0028 · Cited by 2
Minimum Requirements for Reporting Fecal Microbiota Transplant Trial.
Moossavi, S., Bishehsari, F., Ansari, R., Vahedi, H., Nasseri‐Moghaddam, S., Merat, S., Sobhani, I., Keshavarzian, A., & Malekzadeh, R. (2015) · PubMed Central · Cited by 2
Pediatric Fecal Microbiota Transplantation
Mir, S. A. V., Kellermayer, R., & Gulati, A. (2014) · Current Pediatrics Reports · doi:10.1007/s40124-014-0049-5 · Cited by 2
[Fecal microbiota transplantation therapy for patients with gastrointestinal tract diseases].
Osada, T., Ishikawa, D., & Watanabe, S. (2015) · PubMed · doi:10.11405/nisshoshi.112.1973 · Cited by 2
Pediatric Ulcerative Colitis in Siblings
Mamootil, D. (2023) · Cureus · doi:10.7759/cureus.40829 · Cited by 2
“There have also been a few studies in children with fecal microbial transplantation (FMT), as a proposed treatment of UC [20].”
BackgroundТрансплантация фекальной микробиоты в лечении воспалительных заболеваний кишечника
Privalov, M. A., & Sizenko, A. K. (2014) · Likarska sprava · doi:10.31640/ls-2014-11-03 · Cited by 2
Role of the Gut Microbiota in Maintaining GI Health: Highlights on Inflammatory Bowel Disease
Gruber, L., & Haller, D. (2014) · Molecular and integrative toxicology · doi:10.1007/978-1-4471-6539-2_13 · Cited by 3
Recent Update in Fecal Microbiota Transplantation
Kim, H., Kang, K., Kim, S.-J., & Im, E. (2014) · The Korean Journal of Microbiology · doi:10.7845/kjm.2014.4072 · Cited by 2
“궤양성 대장염을 앓고 있는 10명의 어린이를 대상으로 FMT 를 시행하였는데 시행 이 후 일주일을 지켜본 결과 큰 부작용은 나타나지 않았고 78%의 환자에서 임상적인 효능이 관찰되었으 며 33%의 경우 증상이 완화된 관해기(remission)가 나타났다 (Kunde et al., 2013).”
Fecal microbiota transplantation: why, who, how?
Yalçın, S. S., & Kanatlı, M. Ç. (2015) · Pamukkale Medical Journal · doi:10.5505/ptd.2015.22448 · Cited by 2
“Hafif-orta ülseratif koliti olan 7-21 yaşları arasındaki 10 çocuğun yedisinde birinci haftada klinik yanıt elde edilmiş ve altısında da klinik yanıt devam etmiştir [26].”
El trasplante de la microbiota fecal: La coprofagia del presente
García, J. J. B., & Borrego-Ruiz, A. (2024) · UNED repository · Cited by 2
Development of a dual flow microfluidic device for the study of barrier systems
Baldwin, L. (2020) · Repository@Hull (Worktribe) (University of Hull) · Cited by 2
Update on Fecal Microbiota Transplantation In Inflammatory Bowel Diseases
Kwok, S., Choi, B., Choi, J. H., Bassi, S., & Shih, D. Q. (2018) · doi:10.32392/biomed.27 · Cited by 1
Transplantation of encapsulated fecal microbiota: research progress and future trends
Lin, M.-L., & Gao, H. (2026) · World Journal of Pediatrics · doi:10.1007/s12519-026-01056-z · Cited by 1
Strain-level ecological filtering governs microbial colonization of the human gut
Baertschi, I., Jordi, S. B. U., Gardaz, L. J., Bigi, F. V., Sokollik, C., Juillerat, P., & Yılmaz, B. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117775 · Cited by 1
Fecal Microbiota Transplantation: An Interest in IBD?
Kahn, S. A., Goeppinger, S. R., & Rubin, D. T. (2014) · Nestlé Nutrition Institute Workshop series · doi:10.1159/000360715 · Cited by 1
Fecal microbiota transplantation for Clostridium difficile infection: A surgeon׳s perspective
Borody, T. J., & Finlayson, S. (2014) · Seminars in Colon and Rectal Surgery · doi:10.1053/j.scrs.2014.05.013 · Cited by 1
Fecal Microbial Transplant: For Whom, How, and When
Kahn, S. A., & Kaplan, J. L. (2015) · Springer eBooks · doi:10.1007/978-3-319-17169-2_35 · Cited by 1
Russell, G. H. (2015) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000619 · Cited by 1
Clinical Utility and Alterations in Bacterial Flora in Fecal Microbiome Transplantation
Dave, A. A., & Robson, R. L. (2015) · International Journal of Medical Students · doi:10.5195/ijms.2015.135 · Cited by 1
“Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis.21 July 2015.”
BackgroundMethodInfluentialFrancescone, R., & Costa, D. B. V. (2016) · Wiley eBooks · doi:10.1002/9781118982907.ch25 · Cited by 1
Faecal microbiota transplant in a child with very early onset inflammatory bowel disease
Salinas, C. S., Recio, M. I. V., Blasco‐Alonso, J., Nieto, M. J. S., & Navas‐López, V. M. (2018) · Anales de Pediatría (English Edition) · doi:10.1016/j.anpede.2017.10.004 · Cited by 1
Interactions Between Diet and Gut Microbes in Inflammatory Bowel Disease
Martinez, K., & Chang, E. B. (2013) · Clinical Nutrition INSIGHT · doi:10.1097/01.nmd.0000434456.52227.bd · Cited by 1
The microbiota as target for therapeutic intervention in pediatric intestinal diseases
Vecchio, A. L., & Guarino, A. (2016) · Wiley eBooks · doi:10.1002/9781118982907.ch31 · Cited by 1
Advances in Gastrointestinal Surgery
Chattopadhyay, T. K. (2015) · GI surgery annual · doi:10.1007/978-981-10-2010-0_10 · Cited by 1
Fecal Microbial Transplant- A New Hope of Treatment for Ulcerative Colitis
Butta, H., Kapoor, A., Sibal, A., Sardana, R., Bhatia, V., & Mendiratta, L. (2018) · International Journal of Medicine and Public Health · doi:10.5530/ijmedph.2018.1.2 · Cited by 1
Medikamentöse Therapie der CED bei Kindern und Jugendlichen
Keller, K. (2020) · Springer eBooks · doi:10.1007/978-3-662-59104-8_28 · Cited by 1
FEKAL MİKROBİYOTA TRANSPLANTASYONU VE HEMŞİRELİK
Yoldaş, G., & Türeyen, A. (2020) · Journal of Anatolia Nursing and Health Sciences · doi:10.17049/ataunihem.490181 · Cited by 1
Okhotnikova, О. M., Tkacheva, T. M., Romanchuk, A. A., Grishchenko, O. M., & Semenenko, L. V. (2021) · Modern pediatrics Ukraine · doi:10.15574/sp.2021.114.40 · Cited by 1
“Опубліковані результати декількох серій випадків ефективності FMT у дітей з ВК, які не мали переконливих свідчень [39,48,90].”
Unique Challenges in the Diagnosis and Management of the Pediatric IBD Patient
Morganstern, J. A., & Schosheim, A. (2021) · Clinical gastroenterology · doi:10.1007/978-3-030-81780-0_9 · Cited by 1
Update on fecal microbial transplantation for the treatment of inflammatory bowel disease
Llirós, M., Lluansí, A., Peries, L., Bahí, A., Ramió‐Pujol, S., & Aldeguer, X. (2021) · Journal of IMIDs · doi:10.24875/jimids.m21000008 · Cited by 1
Vandenplas, Y., Huys, G. R. B., & Daube, G. (2015) · Springer eBooks · doi:10.1007/978-3-319-17169-2_45 · Cited by 1
Çavdar, M., & Çavdar, M. (2023) · Progress in nutrition · doi:10.23751/pn.v25i2.13775 · Cited by 1
Données immunologiques récentes sur les interactions entre le microbiote et les réponses allergiques
Hoarau, C. (2017) · Elsevier eBooks · doi:10.1016/b978-2-294-74931-5.00004-9 · Cited by 1
Zhang, J. (2020) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya) · Cited by 1
Jiang, Y., Wang, S., Wang, Y., Zhang, X., & Li, S. C. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.18.492592 · Cited by 1
Interaction and Functional Impact of Colorectal Cancer Extracellular Vesicles on Escherichia coli
Maani, R. (2024) · Sheffield Hallam University · doi:10.7190/shu-thesis-00684 · Cited by 1
Metadata
- Authors
- Kunde, S., Pham, A., Bonczyk, S., Crumb, T., Duba, M., Conrad, H., Cloney, D., & Kugathasan, S.
- Affiliations
- Spectrum Health (US)
- Michigan State University (US)
- Emory University (US)
- Corresponding author
- Kunde, Sachin
- Pham, Angela
- Crumb, Teri
- Duba, Meg
- Conrad, Harold
- Cloney, Deborah
- Venue
- Journal of Pediatric Gastroenterology and Nutrition
- Publisher
- Wiley
- Published
- 2013-06
- Volume
- 56
- Issue
- 6
- Pages
- 597-601
- ISSN
- 0277-2116 (ISSN-L)
- 1536-4801
- OpenAlex
- W2121245825
- Cited by
- 314
- References
- 26
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 8 · 2023: 14 · 2022: 14 · 2021: 17 · 2020: 26 · 2019: 26 · 2018: 23 · 2017: 40 · 2016: 34 · 2015: 38 · 2014: 42 · 2013: 16
- FWCI
- 28.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pediatric Gastroenterology and Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Surgery › Anorectal Disease Treatments and Outcomes
- Keywords
- fecal microbiota transplantation, ulcerative colitis, pediatric inflammatory bowel disease, colonic dysbiosis, clinical remission, safety and tolerability, adverse events, disease activity
- MeSH terms
- Administration, Rectal, Adolescent, Adult, Biological Therapy, Child, Colitis, Ulcerative, Family, Feasibility Studies, Feces, Female, Follow-Up Studies, Hospitals, Pediatric, Humans, Male, Michigan, Outpatient Clinics, Hospital, Pilot Projects, Remission Induction, Severity of Illness Index, Therapies, Investigational, Donor Selection, Young Adult, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.